Citation

Quancard J, Simic O, Pissot Soldermann C, Aichholz R, Blatter M, Renatus M, Erbel P, Melkko S, Endres R, Sorge M, Kieffer L, Wagner T, Beltz K, Mcsheehy P, Wartmann M, Régnier CH, Calzascia T, Radimerski T, Bigaud M, Weiss A, Bornancin F, Schlapbach A.: Optimization of the <i>In Vivo</i> Potency of Pyrazolopyrimidine MALT1 Protease Inhibitors by Reducing Metabolism and Increasing Potency in Whole Blood. J Med Chem, Volume 63 (23), 2020

Authors

Aichholz R, Beltz K, Bigaud M, Blatter M, Bornancin F, Calzascia T, Endres R, Erbel P, Kieffer L, Mcsheehy P, Melkko S, Pissot Soldermann C, Quancard J, Radimerski T, Régnier CH, Renatus M, Schlapbach A., Simic O, Sorge M, Wagner T, Wartmann M, Weiss A

Journal

J Med Chem

Year

2020

DOI

10.1021/acs.jmedchem.0c01246

PubMed

33216547

Machine-readable

REST APIRDF